An update on inborn errors of V(D)J recombination

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• V(D)J recombination is essential for adaptive immunity, enabling T and B lymphocytes to generate diverse antigen receptors.
• This process relies on the RAG1-RAG2 recombinase to create DNA double-strand breaks, followed by repair via non-homologous end-joining (c-NHEJ).
• Defects in V(D)J recombination lead to a range of inborn errors of immunity (IEI), including severe combined immunodeficiency (SCID) and immune dysregulation.

Purpose of the Study:

• To review disorders of V(D)J recombination within the context of T-cell development.
• To detail the molecular choreography, including recombinase activity, chromatin accessibility, and DNA damage responses.
• To highlight genotype-phenotype correlations and mechanisms driving immune deficiency and dysregulation.

Main Methods:

• Review of pathogenic variants in genes involved in V(D)J recombination (RAG1, RAG2, NUDCD3, ARTEMIS, LIG4, XLF, XRCC4, PRKDC, ATM, MRN complex, RNF168).
• Analysis of temporal dynamics of recombinase activity, chromatin accessibility, and DNA damage responses during T-cell development.
• Examination of genotype-phenotype correlations and underlying mechanisms of immune compromise.

Main Results:

• Pathogenic variants in V(D)J recombination pathway genes lead to diverse IEIs, affecting cleavage, end processing, and repair phases.
• Specific genetic defects correlate with distinct clinical phenotypes, ranging from SCID to autoimmunity.
• Recent advances in diagnostics (TRECs, repertoire sequencing) and therapeutics are emerging.

Conclusions:

• Understanding V(D)J recombination disorders is critical for diagnosing and managing IEIs.
• Continued integration of clinical observation and molecular discovery is essential for improving patient outcomes.
• Further research is needed to fully elucidate the complexities of adaptive immune development and related disorders.